Targeting phosphodiesterase 5 as a therapeutic option against myocardial ischaemia/reperfusion injury and for treating heart failure

Publisher： John Wiley & Sons Inc

E-ISSN： 1476-5381|175|2|223-231

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.175, Iss.2, 2018-01, pp. : 223-231

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treating ischaemia‐reperfusion injury with prostaglandin E1 reduces the risk of early hepatocellular carcinoma recurrence following liver transplantation

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 9, 2015-11 ,pp. : 1101-1110

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treating ischaemia‐reperfusion injury with prostaglandin E1 reduces the risk of early hepatocellular carcinoma recurrence following liver transplantation

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 269-2813, Iss. 9, 2015-11 ,pp. : 1101-1110

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gasotransmitters and cardioprotection

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 6, 2015-03 ,pp. : 1587-1606

John Wiley & Sons Inc

Access to resources Recommend Favorite

A role of microRNA‐370 in hepatic ischaemia‐reperfusion injury by targeting transforming growth factor‐β receptor II

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 4, 2015-04 ,pp. : 1124-1132

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tollip is a critical mediator of cerebral ischaemia–reperfusion injury

By  

THE JOURNAL OF PATHOLOGY, Vol. 237, Iss. 2, 2015-10 ,pp. : 249-262

John Wiley & Sons Inc

Access to resources Recommend Favorite